Cargando…
Formate Might Be a Novel Potential Serum Metabolic Biomarker for Type 2 Diabetic Peripheral Neuropathy
BACKGROUND: As one of the most frequent complications of type 2 diabetes mellitus (T2DM), diabetic peripheral neuropathy (DPN) shows a profound impact on 50% of patients with symptoms of neuropathic pain, numbness and other paresthesia. No valid serum biomarkers for the prediction of DPN have been i...
Autores principales: | Xu, Weisheng, Xue, Wangsheng, Zhou, Zeyu, Wang, Jiying, Qi, Hui, Sun, Shiyu, Jin, Tong, Yao, Ping, Zhao, Jian-Yuan, Lin, Fuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576463/ https://www.ncbi.nlm.nih.gov/pubmed/37842336 http://dx.doi.org/10.2147/DMSO.S428933 |
Ejemplares similares
-
Association between Serum Biomarkers and Peripheral Neuropathy in Microscopic Polyangiitis
por: Masuda, Yuichi, et al.
Publicado: (2022) -
Blood biomarkers of peripheral neuropathy
por: Rossor, Alexander M., et al.
Publicado: (2022) -
Advances in cardiovascular-related biomarkers to predict diabetic peripheral neuropathy
por: Cheng, Meng-Ke, et al.
Publicado: (2023) -
Peripheral neuropathy in prediabetes and the metabolic syndrome
por: Stino, Amro M, et al.
Publicado: (2017) -
Role of inflammatory biomarkers in diabetic peripheral neuropathy
por: Jin, Heung Yong, et al.
Publicado: (2018)